Compile Data Set for Download or QSAR
Report error Found 34 Enz. Inhib. hit(s) with all data for entry = 10845
Target5-hydroxytryptamine receptor 2A(Human)
Mindset Pharma

US Patent
LigandPNGBDBM573384(US11453689, Compound I-38 | (R)-4-chloro-3- ((1-(m...)
Affinity DataIC50: 500nMAssay Description:i. Prepare the assay buffer following the table below;Reagent ConcentrationTris 50 mMCaCl2  4 mMBSA 0.1% (w/v)Adjust pH to 7.4 followed by 0.2 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/4/2022
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Mindset Pharma

US Patent
LigandPNGBDBM50081701(4-hydroxy-N,N-dimethyltryptamine | N,N-dimethyl-4-...)
Affinity DataIC50: 500nMAssay Description:i. Prepare the assay buffer following the table below;Reagent ConcentrationTris 50 mMCaCl2  4 mMBSA 0.1% (w/v)Adjust pH to 7.4 followed by 0.2 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/4/2022
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Mindset Pharma

US Patent
LigandPNGBDBM573546(US11453689, Compound I-44 | US11453689, Compound I...)
Affinity DataIC50: 500nMAssay Description:i. Prepare the assay buffer following the table below;Reagent ConcentrationTris 50 mMCaCl2  4 mMBSA 0.1% (w/v)Adjust pH to 7.4 followed by 0.2 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/4/2022
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Mindset Pharma

US Patent
LigandPNGBDBM573382(US11453689, Compound I-37 | US11453689, Compound I...)
Affinity DataIC50: 500nMAssay Description:i. Prepare the assay buffer following the table below;Reagent ConcentrationTris 50 mMCaCl2  4 mMBSA 0.1% (w/v)Adjust pH to 7.4 followed by 0.2 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/4/2022
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Mindset Pharma

US Patent
LigandPNGBDBM573684(US11453689, Compound I-49 | 3-(((R)-1- (methyl- d3...)
Affinity DataIC50: 500nMAssay Description:i. Prepare the assay buffer following the table below;Reagent ConcentrationTris 50 mMCaCl2  4 mMBSA 0.1% (w/v)Adjust pH to 7.4 followed by 0.2 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/4/2022
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Mindset Pharma

US Patent
LigandPNGBDBM573546(US11453689, Compound I-44 | US11453689, Compound I...)
Affinity DataIC50: 500nMAssay Description:i. Prepare the assay buffer following the table below;Reagent ConcentrationTris 50 mMCaCl2  4 mMBSA 0.1% (w/v)Adjust pH to 7.4 followed by 0.2 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/4/2022
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Mindset Pharma

US Patent
LigandPNGBDBM573683(US11453689, Compound I-48 | 3-(((R)-1- (methyl- d3...)
Affinity DataIC50: 500nMAssay Description:i. Prepare the assay buffer following the table below;Reagent ConcentrationTris 50 mMCaCl2  4 mMBSA 0.1% (w/v)Adjust pH to 7.4 followed by 0.2 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/4/2022
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Mindset Pharma

US Patent
LigandPNGBDBM573385(US11453689, Compound I-39 | (R)-4-methoxy- 3-((1-(...)
Affinity DataEC50: <1.00E+3nMAssay Description:i. Prepare the assay buffer following the table below;Reagent ConcentrationTris 50 mMCaCl2  4 mMBSA 0.1% (w/v)Adjust pH to 7.4 followed by 0.2 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/4/2022
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Mindset Pharma

US Patent
LigandPNGBDBM573382(US11453689, Compound I-37 | US11453689, Compound I...)
Affinity DataEC50: <1.00E+3nMAssay Description:i. Prepare the assay buffer following the table below;Reagent ConcentrationTris 50 mMCaCl2  4 mMBSA 0.1% (w/v)Adjust pH to 7.4 followed by 0.2 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/4/2022
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Mindset Pharma

US Patent
LigandPNGBDBM573686(US11453689, Compound I-51 | (S)-3- (pyrrolidin-2- ...)
Affinity DataEC50: <1.00E+3nMAssay Description:i. Prepare the assay buffer following the table below;Reagent ConcentrationTris 50 mMCaCl2  4 mMBSA 0.1% (w/v)Adjust pH to 7.4 followed by 0.2 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/4/2022
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Mindset Pharma

US Patent
LigandPNGBDBM573382(US11453689, Compound I-37 | US11453689, Compound I...)
Affinity DataEC50: <1.00E+3nMAssay Description:i. Prepare the assay buffer following the table below;Reagent ConcentrationTris 50 mMCaCl2  4 mMBSA 0.1% (w/v)Adjust pH to 7.4 followed by 0.2 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/4/2022
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Mindset Pharma

US Patent
LigandPNGBDBM573546(US11453689, Compound I-44 | US11453689, Compound I...)
Affinity DataEC50: <1.00E+3nMAssay Description:i. Prepare the assay buffer following the table below;Reagent ConcentrationTris 50 mMCaCl2  4 mMBSA 0.1% (w/v)Adjust pH to 7.4 followed by 0.2 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/4/2022
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Mindset Pharma

US Patent
LigandPNGBDBM573546(US11453689, Compound I-44 | US11453689, Compound I...)
Affinity DataEC50: <1.00E+3nMAssay Description:i. Prepare the assay buffer following the table below;Reagent ConcentrationTris 50 mMCaCl2  4 mMBSA 0.1% (w/v)Adjust pH to 7.4 followed by 0.2 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/4/2022
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Mindset Pharma

US Patent
LigandPNGBDBM573546(US11453689, Compound I-44 | US11453689, Compound I...)
Affinity DataEC50: <1.00E+3nMAssay Description:i. Prepare the assay buffer following the table below;Reagent ConcentrationTris 50 mMCaCl2  4 mMBSA 0.1% (w/v)Adjust pH to 7.4 followed by 0.2 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/4/2022
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Mindset Pharma

US Patent
LigandPNGBDBM50081701(4-hydroxy-N,N-dimethyltryptamine | N,N-dimethyl-4-...)
Affinity DataEC50: <1.00E+3nMAssay Description:i. Prepare the assay buffer following the table below;Reagent ConcentrationTris 50 mMCaCl2  4 mMBSA 0.1% (w/v)Adjust pH to 7.4 followed by 0.2 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/4/2022
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Mindset Pharma

US Patent
LigandPNGBDBM573682(US11453689, Compound I-3 | US11453689, Compound I-...)
Affinity DataEC50: <1.00E+3nMAssay Description:i. Prepare the assay buffer following the table below;Reagent ConcentrationTris 50 mMCaCl2  4 mMBSA 0.1% (w/v)Adjust pH to 7.4 followed by 0.2 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/4/2022
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Mindset Pharma

US Patent
LigandPNGBDBM573682(US11453689, Compound I-3 | US11453689, Compound I-...)
Affinity DataEC50: <1.00E+3nMAssay Description:i. Prepare the assay buffer following the table below;Reagent ConcentrationTris 50 mMCaCl2  4 mMBSA 0.1% (w/v)Adjust pH to 7.4 followed by 0.2 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/4/2022
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Mindset Pharma

US Patent
LigandPNGBDBM573385(US11453689, Compound I-39 | (R)-4-methoxy- 3-((1-(...)
Affinity DataIC50: 2.75E+3nMAssay Description:i. Prepare the assay buffer following the table below;Reagent ConcentrationTris 50 mMCaCl2  4 mMBSA 0.1% (w/v)Adjust pH to 7.4 followed by 0.2 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/4/2022
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Mindset Pharma

US Patent
LigandPNGBDBM573382(US11453689, Compound I-37 | US11453689, Compound I...)
Affinity DataIC50: 2.75E+3nMAssay Description:i. Prepare the assay buffer following the table below;Reagent ConcentrationTris 50 mMCaCl2  4 mMBSA 0.1% (w/v)Adjust pH to 7.4 followed by 0.2 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/4/2022
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Mindset Pharma

US Patent
LigandPNGBDBM573391(US11453689, Compound I-41 | (R)-4-fluoro-3- (pyrro...)
Affinity DataIC50: 2.75E+3nMAssay Description:i. Prepare the assay buffer following the table below;Reagent ConcentrationTris 50 mMCaCl2  4 mMBSA 0.1% (w/v)Adjust pH to 7.4 followed by 0.2 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/4/2022
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Mindset Pharma

US Patent
LigandPNGBDBM573682(US11453689, Compound I-3 | US11453689, Compound I-...)
Affinity DataIC50: 2.75E+3nMAssay Description:i. Prepare the assay buffer following the table below;Reagent ConcentrationTris 50 mMCaCl2  4 mMBSA 0.1% (w/v)Adjust pH to 7.4 followed by 0.2 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/4/2022
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Mindset Pharma

US Patent
LigandPNGBDBM573687(US11453689, Compound I-52 | (S)-4- (benzyloxy)-3- ...)
Affinity DataIC50: 5.00E+3nMAssay Description:i. Prepare the assay buffer following the table below;Reagent ConcentrationTris 50 mMCaCl2  4 mMBSA 0.1% (w/v)Adjust pH to 7.4 followed by 0.2 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/4/2022
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Mindset Pharma

US Patent
LigandPNGBDBM573392(US11453689, Compound I-42 | (S)-4-fluoro-3- ((1-(m...)
Affinity DataIC50: 5.00E+3nMAssay Description:i. Prepare the assay buffer following the table below;Reagent ConcentrationTris 50 mMCaCl2  4 mMBSA 0.1% (w/v)Adjust pH to 7.4 followed by 0.2 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/4/2022
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Mindset Pharma

US Patent
LigandPNGBDBM573687(US11453689, Compound I-52 | (S)-4- (benzyloxy)-3- ...)
Affinity DataEC50:  5.50E+3nMAssay Description:i. Prepare the assay buffer following the table below;Reagent ConcentrationTris 50 mMCaCl2  4 mMBSA 0.1% (w/v)Adjust pH to 7.4 followed by 0.2 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/4/2022
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Mindset Pharma

US Patent
LigandPNGBDBM573689(US11453689, Compound I-54 | (R)-3-((1- (methyl- d3...)
Affinity DataEC50:  5.50E+3nMAssay Description:i. Prepare the assay buffer following the table below;Reagent ConcentrationTris 50 mMCaCl2  4 mMBSA 0.1% (w/v)Adjust pH to 7.4 followed by 0.2 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/4/2022
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Mindset Pharma

US Patent
LigandPNGBDBM573391(US11453689, Compound I-41 | (R)-4-fluoro-3- (pyrro...)
Affinity DataEC50:  5.50E+3nMAssay Description:i. Prepare the assay buffer following the table below;Reagent ConcentrationTris 50 mMCaCl2  4 mMBSA 0.1% (w/v)Adjust pH to 7.4 followed by 0.2 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/4/2022
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Mindset Pharma

US Patent
LigandPNGBDBM573684(US11453689, Compound I-49 | 3-(((R)-1- (methyl- d3...)
Affinity DataEC50:  5.50E+3nMAssay Description:i. Prepare the assay buffer following the table below;Reagent ConcentrationTris 50 mMCaCl2  4 mMBSA 0.1% (w/v)Adjust pH to 7.4 followed by 0.2 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/4/2022
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Mindset Pharma

US Patent
LigandPNGBDBM573683(US11453689, Compound I-48 | 3-(((R)-1- (methyl- d3...)
Affinity DataEC50:  5.50E+3nMAssay Description:i. Prepare the assay buffer following the table below;Reagent ConcentrationTris 50 mMCaCl2  4 mMBSA 0.1% (w/v)Adjust pH to 7.4 followed by 0.2 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/4/2022
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Mindset Pharma

US Patent
LigandPNGBDBM573687(US11453689, Compound I-52 | (S)-4- (benzyloxy)-3- ...)
Affinity DataEC50: >1.00E+4nMAssay Description:i. Prepare the assay buffer following the table below;Reagent ConcentrationTris 50 mMCaCl2  4 mMBSA 0.1% (w/v)Adjust pH to 7.4 followed by 0.2 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/4/2022
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Mindset Pharma

US Patent
LigandPNGBDBM573384(US11453689, Compound I-38 | (R)-4-chloro-3- ((1-(m...)
Affinity DataEC50: >1.00E+4nMAssay Description:i. Prepare the assay buffer following the table below;Reagent ConcentrationTris 50 mMCaCl2  4 mMBSA 0.1% (w/v)Adjust pH to 7.4 followed by 0.2 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/4/2022
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Mindset Pharma

US Patent
LigandPNGBDBM573404(US11453689, Compound I-43 | (R)-4- (benzyloxy)-3- ...)
Affinity DataEC50: >1.00E+4nMAssay Description:i. Prepare the assay buffer following the table below;Reagent ConcentrationTris 50 mMCaCl2  4 mMBSA 0.1% (w/v)Adjust pH to 7.4 followed by 0.2 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/4/2022
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Mindset Pharma

US Patent
LigandPNGBDBM573392(US11453689, Compound I-42 | (S)-4-fluoro-3- ((1-(m...)
Affinity DataEC50: >1.00E+4nMAssay Description:i. Prepare the assay buffer following the table below;Reagent ConcentrationTris 50 mMCaCl2  4 mMBSA 0.1% (w/v)Adjust pH to 7.4 followed by 0.2 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/4/2022
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Mindset Pharma

US Patent
LigandPNGBDBM573551(US11453689, Compound I-45 | (R)-4- (benzyloxy)-3- ...)
Affinity DataEC50: >1.00E+4nMAssay Description:i. Prepare the assay buffer following the table below;Reagent ConcentrationTris 50 mMCaCl2  4 mMBSA 0.1% (w/v)Adjust pH to 7.4 followed by 0.2 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/4/2022
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Mindset Pharma

US Patent
LigandPNGBDBM573551(US11453689, Compound I-45 | (R)-4- (benzyloxy)-3- ...)
Affinity DataEC50: >1.00E+4nMAssay Description:i. Prepare the assay buffer following the table below;Reagent ConcentrationTris 50 mMCaCl2  4 mMBSA 0.1% (w/v)Adjust pH to 7.4 followed by 0.2 ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/4/2022
Entry Details
US Patent